Evidence map›Paper›PMID 35854131›Full record

ArticleEuropean journal of clinical nutrition2022

Vitamin C and folate status in hereditary fructose intolerance.

Ainara Cano, Carlos Alcalde, Amaya Belanger-Quintana, Elvira Cañedo-Villarroya, Leticia Ceberio, Silvia Chumillas-Calzada, Patricia Correcher, María Luz Couce, Dolores García-Arenas, Igor Gómez and 12 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in European journal of clinical nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 15 institutions in 1 country.

Ainara CanoBiocruces Bizkaia Health Research Institute, 48093, Barakaldo, Spain.
Carlos AlcaldePaediatrics Unit, Río Hortega University Hospital, 47012, Valladolid, Spain.
Amaya Belanger-QuintanaMetabolic Diseases Unit, Department of Paediatrics, Ramón y Cajal Hospital, 28034, Madrid, Spain.
Elvira Cañedo-VillarroyaDepartment of Metabolism Diseases and Nutrition, Niño Jesús University Children´s Hospital, 28009, Madrid, Spain.
Leticia CeberioBiocruces Bizkaia Health Research Institute, 48093, Barakaldo, Spain.
Silvia Chumillas-Calzada12 de Octubre University Hospital, CIBERER, MetabERN, 28041, Madrid, Spain.
Patricia CorrecherNutrition and Metabolic diseases Unit, La Fe University Hospital, 46026, Valencia, Spain.
María Luz CouceUnit of Diagnosis and Treatment of Congenital Metabolic Diseases, Department of Pediatrics, IDIS-Health Research Institute of Santiago de Compostela. CIBERER. MetabERN. Santiago de Compostela University Clinical Hospital, 15704, Santiago de Compostela, Spain.ORCID http://orcid.org/0000-0003-4861-9905
Dolores García-ArenasDepartment of Paediatric Gastroenterology, Hepatology and Nutrition, Sant Joan de Déu Hospital, 08950, Barcelona, Spain.
Igor GómezAraba University Hospital, 01009, Vitoria-Gasteiz, Spain.
Tomás HernándezPaediatric Service, Albacete University Hospital, 02006, Castilla-La Mancha, Spain.
Elsa Izquierdo-GarcíaPharmacy Department, Infanta Leonor University Hospital, 28031, Madrid, Spain.ORCID http://orcid.org/0000-0002-2173-1027
Dámaris Martínez ChicanoDepartment of Paediatric Gastroenterology, Hepatology and Nutrition, Sant Joan de Déu Hospital, 08950, Barcelona, Spain.
Montserrat Morales12 de Octubre University Hospital, CIBERER, MetabERN, 28041, Madrid, Spain.
Consuelo Pedrón-GinerDepartment of Metabolism Diseases and Nutrition, Niño Jesús University Children´s Hospital, 28009, Madrid, Spain.
Estrella Petrina JáureguiClinical Nutrition Section, Navarra University Hospital, 31008, Pamplona, Spain.ORCID http://orcid.org/0000-0001-8189-7056
Luis Peña-QuintanaPaediatric Gastroenterology, Hepatology and Nutrition Unit, Mother and Child Insular University Hospital complex, Asociación Canaria para la Investigación Pediátrica (ACIP), CIBEROBN. University Institute for Research in Biomedical and Health Sciences, University of Las Palmas de Gran Canaria, 35016, Las Palmas de Gran Canaria, Spain.
Paula Sánchez-PintosUnit of Diagnosis and Treatment of Congenital Metabolic Diseases, Department of Pediatrics, IDIS-Health Research Institute of Santiago de Compostela. CIBERER. MetabERN. Santiago de Compostela University Clinical Hospital, 15704, Santiago de Compostela, Spain.
Juliana Serrano-NietoPaediatric Service, Málaga Regional University Hospital (HRU), 29010, Málaga, Spain.
María Unceta SuarezBiochemistry Laboratory, Metabolism Area, Cruces University Hospital, 48903, Barakaldo, Spain.
Isidro Vitoria MiñanaNutrition and Metabolic diseases Unit, La Fe University Hospital, 46026, Valencia, Spain.
Javier de Las HerasBiocruces Bizkaia Health Research Institute, 48093, Barakaldo, Spain. javier.delasherasmontero@osakidetza.eus.ORCID http://orcid.org/0000-0001-5663-537X
BioCruces Health research Institute · ESHospital Infantil Universitario Niño Jesús · ESHospital Sant Joan de Déu Barcelona · ESHospital Universitari i Politècnic La Fe · ESInstituto de Investigación Sanitaria de Santiago · ESResearch Institute Hospital 12 de Octubre · ESHospital de Cruces · ESHospital Regional Universitario de Málaga · ESHospital Universitario Araba · ESHospital Universitario Infanta Leonor · ESHospital Universitario Río Hortega · ESInstituto Cajal · ESUniversidad de Las Palmas de Gran Canaria · ESUniversidad de Navarra · ESUniversity of the Basque Country · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHereditary fructose intolerance (HFI) is a rare inborn error of fructose metabolism caused by the deficiency of aldolase B. Since treatment consists of a fructose-, sucrose- and sorbitol-restrictive diet for life, patients are at risk of presenting vitamin deficiencies. Although there is no published data on the status of these vitamins in HFI patients, supplementation with vitamin C and folic acid is common. Therefore, the aim of this study was to assess vitamin C and folate status and supplementation practices in a nationwide cohort of HFI patients.

methodsVitamin C and folic acid dietary intake, supplementation and circulating levels were assessed in 32 HFI patients and 32 age- and sex-matched healthy controls.

resultsMost of the HFI participants presented vitamin C (96.7%) and folate (90%) dietary intake below the recommended population reference intake. Up to 69% received vitamin C and 50% folic acid supplementation. Among HFI patients, 15.6% presented vitamin C and 3.1% folate deficiency. The amount of vitamin C supplementation and plasma levels correlated positively (R = 0.443; p = 0.011). Interestingly, a higher percentage of non-supplemented HFI patients were vitamin C deficient when compared to supplemented HFI patients (30% vs. 9.1%; p = 0.01) and to healthy controls (30% vs. 3.1%; p < 0.001).

conclusionsOur results provide evidence for the first time supporting vitamin C supplementation in HFI. There is great heterogeneity in vitamin supplementation practices and, despite follow-up at specialised centres, vitamin C deficiency is common. Further research is warranted to establish optimal doses of vitamin C and the need for folic acid supplementation in HFI.

Indexed as

Fructose IntoleranceAscorbic AcidFolic AcidFructoseHumansVitamin B 12VitaminsAscorbic AcidFolic AcidFructoseVitamin B 12Vitamins

Identifiers

PMID35854131
PMCPMC9708598
OpenAlexW4286222400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.